Predicting poor left ventricular function recovery in Peripartum cardiomyopathy

References

• Ricke-Hoch M, Pfeffer TJ, Hilfiker-Kleiner D. Peripartum cardiomyopathy: basic mechanisms and hope for new therapies. Cardiovasc Res. 2020;116(3):520–531. doi:10.1093/cvr/cvz252.
   PubMed Web of Science ®Google Scholar
• Bauersachs J, König T, van der Meer P, et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the heart failure association of the European Society of cardiology study group on peripartum cardiomyopathy. Eur J Heart Fail. 2019;21(7):827–843. doi:10.1002/ejhf.1493.
   PubMed Web of Science ®Google Scholar
• Sliwa K, Petrie MC, Hilfiker‐Kleiner D, et al. Long‐term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the heart failure association of the European society of cardiology study group on peripartum cardiomyopathy. Eur J Heart Fail. 2018;20(6):951–962. doi:10.1002/ejhf.1178.
   PubMed Web of Science ®Google Scholar
• Sliwa K. Peripartum cardiomyopathy: from pathophysiology to management. Elsevier Science; 2021. doi:10.1016/C2018-0-02473-1.
   Google Scholar
• Bhattacharyya A, Basra SS, Sen P, et al. Peripartum cardiomyopathy: a review. Texas Heart Inst J. 2012;39(1):8.
   PubMed Web of Science ®Google Scholar
• Biteker M, Ilhan E, Biteker G, et al. Delayed recovery in peripartum cardiomyopathy: an indication for long‐term follow‐up and sustained therapy. Eur J Heart Fail. 2012;14(8):895–901. doi:10.1093/eurjhf/hfs070.
   PubMed Web of Science ®Google Scholar
• Pearson GD, Veille J-C, Rahimtoola S, et al. Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (national institutes of health) workshop recommendations and review. Jama. 2000;283(9):1183–1188. doi:10.1001/jama.283.9.1183.
   PubMed Web of Science ®Google Scholar
• Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16):2050–2055. doi:10.1161/01.CIR.0000162478.36652.7E.
   PubMed Web of Science ®Google Scholar
• Sliwa K, Bauersachs J, Arany Z, et al. Peripartum cardiomyopathy: from genetics to management. Eur Heart J. 2021;42(32):3094–3102. doi:10.1093/eurheartj/ehab458.
   PubMed Web of Science ®Google Scholar
• McNamara DM, Elkayam U, Alharethi R, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (investigations of pregnancy-associated cardiomyopathy). J Am Coll Cardiol. 2015;66(8):905–914. doi:10.1016/j.jacc.2015.06.1309.
   PubMed Web of Science ®Google Scholar
• Dolgin M, Association NYH, Fox AC, , et al. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. Boston, MA: Lippincott Williams and Wilkins; 1994.
   Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368.
   PubMed Web of Science ®Google Scholar
• Khatib R, Sabir FR, Omari C, et al. Managing drug-induced QT prolongation in clinical practice. Postgrad Med J. 2021;97(1149):452–458. doi:10.1136/postgradmedj-2020-138661.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–270. doi:10.1093/ehjci/jev014.
   PubMed Web of Science ®Google Scholar
• Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr. 2017;30(4):303–371. doi:10.1016/j.echo.2017.01.007.
   PubMed Web of Science ®Google Scholar
• Goland S, Bitar F, Modi K, et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail. 2011;17(5):426–430. doi:10.1016/j.cardfail.2011.01.007.
   PubMed Web of Science ®Google Scholar
• Duran N, Günes H, Duran I, et al. Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet. 2008;101(2):137–140. doi:10.1016/j.ijgo.2007.11.007.
   PubMed Web of Science ®Google Scholar
• Zipes DP, Libby P, Bonow RO, et al. Braunwald’s heart disease e-book: a textbook of cardiovascular medicine. Elsevier Health Sciences; 2018. https://books.google.co.id/books?id=LwBGDwAAQBAJ.
   Google Scholar
• Hosseinpour A, Hosseinpour H, Kheshti F, et al. Prognostic value of various markers in recovery from peripartum cardiomyopathy: a systematic review and meta‐analysis. ESC Heart Fail. 2022;9(5):3483–3495. doi:10.1002/ehf2.14085.
   PubMed Web of Science ®Google Scholar
• Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006;152(3):509–513. doi:10.1016/j.ahj.2006.02.008.
   PubMed Web of Science ®Google Scholar
• Hoevelmann J, Muller E, Azibani F, et al. Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM). Clin Res Cardiol. 2021;110(8):1259–1269. doi:10.1007/s00392-021-01808-z.
   PubMed Web of Science ®Google Scholar
• Bello N, Rendon ISH, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62(18):1715–1723. doi:10.1016/j.jacc.2013.08.717.
   PubMed Web of Science ®Google Scholar
• Ekizler FA, Cay S. A novel marker of persistent left ventricular systolic dysfunction in patients with peripartum cardiomyopathy: monocyte count-to-HDL cholesterol ratio. BMC Cardiovasc Disord. 2019;19(1):114. doi:10.1186/s12872-019-1100-9.
   PubMedGoogle Scholar
• Li W, Li H, Long Y. Clinical characteristics and long-term predictors of persistent left ventricular systolic dysfunction in peripartum cardiomyopathy. Can J Cardiol. 2016;32(3):362–368. doi:10.1016/j.cjca.2015.07.733.
   PubMed Web of Science ®Google Scholar